A series of tissue changes may be associated with an increased risk of developing aggressive breast cancer among women with benign breast disease, and poorer rates of survival among women with invasive breast cancer.
NIH researchers discover tissue biomarker that may indicate higher risk of aggressive breast cancer development and death
